Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, ascorbic acid, niacin, folic acid, ferrous fumarate, calcium carbonate, cholecalciferol, vitamin e acetate, potassium iodide, zinc oxide, choline bitartrate, doconexent, and icosapent

×

Overview

What is Gesticare DHA?

Gesticare DHA includes a light pink coated oblong-shaped tablet with “P-114” debossed on one side of the tablet and a natural DHA softgel capsule containing a pale orange oil.



What does Gesticare DHA look like?



What are the available doses of Gesticare DHA?

Sorry No records found.

What should I talk to my health care provider before I take Gesticare DHA?

Sorry No records found

How should I use Gesticare DHA?

Gesticare DHA is indicated to provide vitamin/mineral and DHA omega-3 fatty acid supplement to women throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. Gesticare DHA may be beneficial in improving the nutritional status of women prior to conception.

One Gesticare tablet and one DHA capsule daily or as directed by a physician.


What interacts with Gesticare DHA?

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.


WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.



What are the warnings of Gesticare DHA?

Studies from Britain and the U.S. have shown an increased risk of developing hepatocellular carcinoma in combined oral contraceptive users. However, these cancers are rare. There is insufficient data to determine whether POPs increase the risk of developing hepatic neoplasia.


What are the precautions of Gesticare DHA?

Folic acid in doses above 0.1mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.


What are the side effects of Gesticare DHA?

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.


What should I look out for while using Gesticare DHA?

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.


What might happen if I take too much Gesticare DHA?

Sorry No Records found


How should I store and handle Gesticare DHA?

Qutenza contains capsaicin capable of producing severe irritation of eyes, skin, respiratory tract and mucous membranes. Do not dispense Qutenza to patients for self-administration. It is critical that health care professionals who administer Qutenza have completely familiarized themselves with proper dosing, handling, and disposal procedures before handling Qutenza to avoid accidental or inadvertent capsaicin exposure to themselves or others []. RX onlyDistributed by:Azur Pharma, Inc.1818 Market Street, Suite 2350Philadelphia, PA 19103To report a serious adverse event or obtain product information, contact (800) 890 3098.Gesticare is a registered trademark of Azur Pharma International II Limited.life’s DHARX onlyDistributed by:Azur Pharma, Inc.1818 Market Street, Suite 2350Philadelphia, PA 19103To report a serious adverse event or obtain product information, contact (800) 890 3098.Gesticare is a registered trademark of Azur Pharma International II Limited.life’s DHARX onlyDistributed by:Azur Pharma, Inc.1818 Market Street, Suite 2350Philadelphia, PA 19103To report a serious adverse event or obtain product information, contact (800) 890 3098.Gesticare is a registered trademark of Azur Pharma International II Limited.life’s DHARX onlyDistributed by:Azur Pharma, Inc.1818 Market Street, Suite 2350Philadelphia, PA 19103To report a serious adverse event or obtain product information, contact (800) 890 3098.Gesticare is a registered trademark of Azur Pharma International II Limited.life’s DHARX onlyDistributed by:Azur Pharma, Inc.1818 Market Street, Suite 2350Philadelphia, PA 19103To report a serious adverse event or obtain product information, contact (800) 890 3098.Gesticare is a registered trademark of Azur Pharma International II Limited.life’s DHARX onlyDistributed by:Azur Pharma, Inc.1818 Market Street, Suite 2350Philadelphia, PA 19103To report a serious adverse event or obtain product information, contact (800) 890 3098.Gesticare is a registered trademark of Azur Pharma International II Limited.life’s DHARX onlyDistributed by:Azur Pharma, Inc.1818 Market Street, Suite 2350Philadelphia, PA 19103To report a serious adverse event or obtain product information, contact (800) 890 3098.Gesticare is a registered trademark of Azur Pharma International II Limited.life’s DHARX onlyDistributed by:Azur Pharma, Inc.1818 Market Street, Suite 2350Philadelphia, PA 19103To report a serious adverse event or obtain product information, contact (800) 890 3098.Gesticare is a registered trademark of Azur Pharma International II Limited.life’s DHA


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Non-Clinical Toxicology
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.

Change in contraceptive effectiveness associated with co-administration of other products:

a. Contraceptive effectiveness may be reduced when hormonal contraceptives are co-administered with antibiotics, anticonvulsants, and other drugs that increase the metabolism of contraceptive steroids. This could result in unintended pregnancy or breakthrough bleeding. Examples include rifampin, barbiturates, phenylbutazone, phenytoin, carbamazepine, felbamate, oxcarbazepine, topiramate, and griseofulvin.

b. Several of the anti-HIV protease inhibitors have been studied with co-administration of oral contraceptives; significant changes (increase and decrease) in the plasma levels of the estrogen and progestin have been noted in some cases. The safety and efficacy of OC products may be affected with the co-administration of anti-HIV protease inhibitors. Health care providers should refer to the label of the individual anti-HIV protease inhibitors for further drug-drug interaction information.

c. Herbal products containing St. John's Wort (hypericum perforatum) may induce hepatic enzymes (cytochrome P450) and p-glycoprotein transporter and may reduce the effectiveness of contraceptive steroids. This may also result in breakthrough bleeding.

Folic acid in doses above 0.1mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).